Stevenage, United Kingdom

Diane Mary Coe

USPTO Granted Patents = 40 

 

 

Average Co-Inventor Count = 4.0

ph-index = 10

Forward Citations = 224(Granted Patents)


Location History:

  • Hertfordshire, GB (2014)
  • Stevenage, GB (2006 - 2019)

Company Filing History:


Years Active: 2006-2019

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Cyclic Di-Nucleotides
Pyrrolo[3,2-D]Pyrimidine Derivatives
Pyrazolopyrimidine Compounds
Pyrrolopyrimidines
Purine Derivatives
Adenine Derivatives
N-Cyclobutyl-Imidazopyridine-Methylamine
Phenethanolamine Derivatives
TRPV1 Antagonists
CRAC Channel Inhibitors
Non-Steroidal Glucocorticoid Inhibitors
Phosphodiesterase Inhibitors
40 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Diane Mary Coe

Introduction: Meet Diane Mary Coe, a prolific inventor based in Stevenage, GB, whose innovative spirit has led to the creation of 40 patents in the field of pharmaceuticals. Her groundbreaking work in developing compounds and derivatives for the treatment of various diseases and conditions has significantly advanced the medical industry.

Latest Patents: Among Diane Mary Coe's latest patents is the discovery of cyclic di-nucleotides as modulators of STING. These compounds have shown promise in the modulation of STING, a key player in the immune response, making them valuable in the treatment of inflammation, allergic and autoimmune diseases, infectious diseases, cancer, and as vaccine adjuvants. Additionally, her work on Pyrrolo[3,2-D]pyrimidine derivatives as inducers of human interferon highlights her dedication to finding solutions for allergic diseases, inflammatory conditions, infectious diseases, and cancer treatment.

Career Highlights: Diane Mary Coe has made significant contributions to the pharmaceutical industry through her collaborations with renowned companies such as Glaxo Group Limited and GlaxoSmithKline LLC. Her expertise and innovative approach have led to the development of novel compounds that have the potential to revolutionize the field of medicine.

Collaborations: Throughout her career, Diane Mary Coe has worked closely with esteemed colleagues such as Stephen Allan Smith and Keith Biggadike. Together, they have driven forward projects that have paved the way for new treatments and therapies, showcasing the power of collaboration in fueling innovation.

Conclusion: In conclusion, Diane Mary Coe's remarkable achievements in the realm of pharmaceutical inventions underscore her passion for improving human health and well-being. Her dedication to pushing the boundaries of scientific discovery serves as an inspiration to aspiring inventors and underscores the importance of innovation in shaping a better future for all.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…